Evidence map›Paper›PMID 31610847›Full record

ArticleeLife2019

Metabolic stress is a primary pathogenic event in transgenic

Emelyne Teo, Sudharshan Ravi, Diogo Barardo, Hyung-Seok Kim, Sheng Fong, Amaury Cazenave-Gassiot, Tsze Yin Tan, Jianhong Ching, Jean-Paul Kovalik, Markus R Wenk and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Functional Analysis of Late-Onset Alzheimer's Disease Risk Genes inbioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Studying the mechanisms of neurodegeneration:Frontiers in cellular neuroscience · 2025
    Review
  9. Article
  10. Article
  11. Olfactory dysfunction as an early pathogenic indicator inFrontiers in aging neuroscience · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Using Optogenetics to Model Cellular Effects of Alzheimer's Disease.International journal of molecular sciences · 2023
    Review
  16. Brain aerobic glycolysis and resilience in Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Emelyne TeoNUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore, Singapore.ORCID 0000-0001-5050-4109
Sudharshan RaviDepartment of Chemical and Biological Engineering, University of Buffalo, Buffalo, United States.
Diogo BarardoScience Division, Yale-NUS College, Singapore, Singapore.ORCID 0000-0001-6177-0728
Hyung-Seok KimScience Division, Yale-NUS College, Singapore, Singapore.
Sheng FongGeriatric Medicine Senior Residency Programme, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
Amaury Cazenave-GassiotDepartment of Biochemistry, National University of Singapore, Singapore, Singapore.
Tsze Yin TanCardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, Singapore, Singapore.
Jianhong ChingCardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, Singapore, Singapore.
Jean-Paul KovalikCardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, Singapore, Singapore.ORCID 0000-0003-3654-8193
Markus R WenkDepartment of Biochemistry, National University of Singapore, Singapore, Singapore.
Rudiyanto GunawanDepartment of Chemical and Biological Engineering, University of Buffalo, Buffalo, United States.
Philip K MooreDepartment of Pharmacology, National University of Singapore, Singapore, Singapore.
Barry HalliwellDepartment of Biochemistry, National University of Singapore, Singapore, Singapore.
Nicholas TolwinskiScience Division, Yale-NUS College, Singapore, Singapore.
Jan GruberScience Division, Yale-NUS College, Singapore, Singapore.ORCID 0000-0003-3329-3789
National University of Singapore · SGDuke-NUS Medical School · SGYale-NUS College · SGETH Zurich · CHSingHealth Duke-NUS Academic Medical Centre · SGUniversity at Buffalo, State University of New York · USUniversity of Washington · US

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Ministry of Education - Singapore 2014-T2-2-120Ministry of Education - Singapore NGS ScholarshipMinistry of Education - Singapore R-184-000-230-112NIH HHS P40 OD010440Swiss National Science Foundation 163390Yale-NUS IG17-LR006
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease affecting the elderly worldwide. Mitochondrial dysfunction has been proposed as a key event in the etiology of AD. We have previously modeled amyloid-beta (Aβ)-induced mitochondrial dysfunction in a transgenic

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansCitric Acid CycleDisease Models, AnimalHumansHypoglycemic AgentsKetoglutarate Dehydrogenase ComplexMetabolic Flux AnalysisMetforminMitochondriaNeuronsProtein AggregatesProtein CarbonylationAmyloid beta-PeptidesHypoglycemic AgentsKetoglutarate Dehydrogenase ComplexMetforminProtein Aggregatesamyloid betaC. elegansmetabolismmetforminmitochondrianeuroscienceTCA cycle

Identifiers

PMID31610847
PMCPMC6794093
OpenAlexW2980884142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.